ConductScience.org, home

Paper32255486

Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.

Nayagam S and 23 others. Clin Infect Dis, 2021. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning. Papers, record 32255486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32255486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
2.41
iCite
Revised in PubMed
2025-05-30
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nayagam SShevanthi
2Chan PPolin
3Zhao KKun
4Sicuri EElisa
5Wang XXiaochun
6Jia JJidong
7Wei LLai
8Walsh NNick
9Rodewald LELance E
10Zhang GGuomin
11Ailing WWang
12Zhang LLan
13Chang JHJoo H
14Hou WWeiWei
15Qiu YYingpeng
16Sui BBinyan
17Xiao YYue
18Zhuang HHui
19Thursz MRM R
20Scano FFabio

Source PubMed

See all 24 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Hepatitis B, ChronicMajor topic
Antiviral Agents
China
Hepatitis B Vaccines
Hepatitis B virus
Humans

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
001World Health OrganizationInternationalPubMed
MC_PC_19012Medical Research CouncilUnited KingdomPubMed
MR/L002086/1Medical Research CouncilUnited KingdomPubMed
MR/R015600/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in32255492Global Hepatitis B Virus Elimination by 2030: China Is Pivotal and Instructive.https://conductscience.org/library/papers/32255492

Source PubMed

Download CSV of comments and corrections

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126146815World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.Hepatology2015https://conductscience.org/library/papers/26146815PubMed
227751400The effects of China's universal two-child policy.Lancet2016https://conductscience.org/library/papers/27751400PubMed
324004482The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya.Malar J2013https://conductscience.org/library/papers/24004482PubMed
429599078Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.Lancet Gastroenterol Hepatol2018https://conductscience.org/library/papers/29599078PubMed
521641026Towards an improved investment approach for an effective response to HIV/AIDS.Lancet2011https://conductscience.org/library/papers/21641026PubMed
620553944Dynamical behavior of a hepatitis B virus transmission model with vaccination.J Theor Biol2010https://conductscience.org/library/papers/20553944PubMed
726808342Cancer statistics in China, 2015.CA Cancer J Clin2016https://conductscience.org/library/papers/26808342PubMed
826804359Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature.Health Econ2016https://conductscience.org/library/papers/26804359PubMed
920586991Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.Value Health2009https://conductscience.org/library/papers/20586991PubMed
1017495790Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.MMWR Morb Mortal Wkly Rep2007https://conductscience.org/library/papers/17495790PubMed
1116249217A mathematical model to estimate global hepatitis B disease burden and vaccination impact.Int J Epidemiol2005https://conductscience.org/library/papers/16249217PubMed
128241859Cost-benefit analysis.BMJ1993https://conductscience.org/library/papers/8241859PubMed
1325329072Impact of a new reimbursement program on hepatitis B antiviral medication cost and utilization in Beijing, China.PLoS One2014https://conductscience.org/library/papers/25329072PubMed
1424653626Annual report on status of cancer in China, 2010.Chin J Cancer Res2014https://conductscience.org/library/papers/24653626PubMed
1528418296Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China.Emerg Infect Dis2017https://conductscience.org/library/papers/28418296PubMed
1626231459Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.Lancet2015https://conductscience.org/library/papers/26231459PubMed
1721998648Economic returns to investment in AIDS treatment in low and middle income countries.PLoS One2011https://conductscience.org/library/papers/21998648PubMed
1824670067The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden.BMC Cancer2014https://conductscience.org/library/papers/24670067PubMed
1915602167Cost of chronic hepatitis B infection in China.J Clin Gastroenterol2004https://conductscience.org/library/papers/15602167PubMed
2027638356Requirements for global elimination of hepatitis B: a modelling study.Lancet Infect Dis2016https://conductscience.org/library/papers/27638356PubMed

See all 28 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42483732Chronic Hepatitis B in the Asia-Pacific Region: Results of the 2023 Global Burden of Disease Study.J Clin Transl Hepatol2026https://conductscience.org/library/papers/42483732PubMed
42277148Spatio-temporal clustering characteristics of hepatitis B in China: an 18-year study.Sci Rep2026https://conductscience.org/library/papers/42277148PubMed
42050466Medication adherence and associated factors in patients with chronic hepatitis B in Zhejiang Province, Eastern China.BMC Public Health2026https://conductscience.org/library/papers/42050466PubMed
41263854Curative care expenditure across different comorbidity states of chronic hepatitis B: a prevalence study in Sichuan Province, China.BMJ Open2025https://conductscience.org/library/papers/41263854PubMed
41127124Feasibility of eliminating adult hepatitis B in Guangdong by 2030: A modeling study.Infect Dis Model2026https://conductscience.org/library/papers/41127124PubMed
40937078Epidemiology, Achievements, and Challenges in the Elimination of Hepatitis B in China.J Clin Transl Hepatol2025https://conductscience.org/library/papers/40937078PubMed
40265061Changes in the prevalence of hepatitis B virus and its related factors in Inner Mongolia between 2006 and 2020.Front Public Health2025https://conductscience.org/library/papers/40265061PubMed
40104634Modeling hepatitis B-related deaths in China to achieve the WHO's impact target.Infect Dis Model2025https://conductscience.org/library/papers/40104634PubMed
40044428[Recent advances in epidemiology, prevention and treatment of hepatitis B in China].Zhonghua Gan Zang Bing Za Zhi2025https://conductscience.org/library/papers/40044428PubMed
39680440Effect of Health Literacy on Antiviral Treatment of Hepatitis B: Instrumental Variable Analysis.JMIR Public Health Surveill2024https://conductscience.org/library/papers/39680440PubMed
39315090New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020.Lancet Reg Health West Pac2024https://conductscience.org/library/papers/39315090PubMed
38660313Comparison of the effectiveness four years after Homo/Hetero prime-boost with 10 μg HP and 20 μg CHO recombinant hepatitis B vaccine at 1 and 6 months in maternal HBsAg-negative children.Front Immunol2024https://conductscience.org/library/papers/38660313PubMed
38176692Comprehensive approach to controlling chronic hepatitis B in China.Clin Mol Hepatol2024https://conductscience.org/library/papers/38176692PubMed
37675271Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies.JHEP Rep2023https://conductscience.org/library/papers/37675271PubMed
37349664Impact and Cost-Effectiveness of Biomedical Interventions on Adult Hepatitis B Elimination in China: A Mathematical Modelling Study.J Epidemiol Glob Health2023https://conductscience.org/library/papers/37349664PubMed
36747172Changing incidence of hepatitis B and persistent infection risk in adults: a population-based follow-up study from 2011 in China.BMC Public Health2023https://conductscience.org/library/papers/36747172PubMed
36423153Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.Viruses2022https://conductscience.org/library/papers/36423153PubMed
35836769Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China.J Clin Transl Hepatol2022https://conductscience.org/library/papers/35836769PubMed
35796158Costs and health impact of delayed implementation of a national hepatitis B treatment program in China.J Glob Health2022https://conductscience.org/library/papers/35796158PubMed
35198638Question Answering System Based on Knowledge Graph in Traditional Chinese Medicine Diagnosis and Treatment of Viral Hepatitis B.Biomed Res Int2022https://conductscience.org/library/papers/35198638PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32255486

GET https://conductscience.org/api/papers/v1/32255486/authors?page=2